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Abstract Colony-stimulating factor 1 receptor (CSF1R)
is expressed in monocytes/macrophages and dendritic cells.
These cells play important roles in the innate immune
response, which is regarded as an important aspect of
asthma development. Genetic alterations in the CSF1R
gene may contribute to the development of asthma. We
investigated whether CSF1R gene polymorphisms were
associated with the risk of asthma. Through direct DNA
sequencing of the CSF1R gene, we identiWed 28 single
nucleotide polymorphisms (SNPs) and genotyped them in
303 normal controls and 498 asthmatic patients. Expression
of CSF1R protein and mRNA were measured on CD14-
positive monocytes and neutrophils in peripheral blood of
asthmatic patients using Xow cytometry and real-time PCR.
Among the 28 polymorphisms, two intronic polymorphism
(+20511C>T and +22693T>C) were associated with the
risk of asthma by logistic regression analysis. The frequen-
cies of the minor allele at CSF1R + 20511C>T and
+22693T>C were higher in asthmatic subjects than in nor-
mal controls (4.6 vs. 7.7%, p = 0.001 in co-dominant and
dominant models; 16.4 vs. 25.8%, p = 0.0006 in a recessive
model). CSF1R mRNA levels in neutrophils of the asth-
matic patients having the +22693CC allele were higher
than in those having the +22693TT allele (p = 0.026). Asth-
matic patients with the +22693CC allele also showed sig-
niWcantly higher CSF1R expression on CD14-positive
monocytes and neutrophils than did those with the
+22693TT allele (p = 0.045 and p =0 . 0 4 4 ) .  T h e  + 20511C>
T SNP had no association with CSF1R mRNA or
protein expression. In conclusion, the minor allele at
CSF1R + 22693T>C may have a susceptibility eVect in the
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development of asthma, via increased CSF1R protein and
mRNA expression in inXammatory cells.
Introduction
Asthma and its phenotypes are complex traits induced by
interactions between the surrounding environment and mul-
tiple disease susceptibility genetic factors (Sengler et al.
2002). Allergic asthma has been recognized as an antigen-
dependent T-helper type 2 (Th2)-related disease with a
cytokine response proWle that includes interleukin (IL)-4,
IL-5, and IL-13. These cytokines play important roles in the
coordination and persistence of the airway inXammatory
process in allergic asthma (Cohn et al. 2004).
Recently, the innate, non-antigen-dependent immune
system has received as much attention in the pathogenesis
of asthma as an antigen-dependent adaptive immune
response because adaptive immune responses are depen-
dent on activation of the innate system (Kanzler et al.
2007). Many innate immune receptors, such as the Toll-like
receptors (TLR), NOD proteins, Dectin, CD14, and collec-
tins, have been discovered (Beutler 2004). TLR2 is associ-
ated with increased allergic inXammation and airway
hyper-reactivity in a murine allergic model (Redecke et al.
2004), whereas TLR4 ligands can decrease allergic
responses (Velasco et al. 2005). In these processes, den-
dritic cells (DCs) play a central role in initiating and regu-
lating the adaptive and innate immune responses (Iwasaki
and Medzhitov 2004).
Colony-stimulating factor 1 (CSF1, also referred to as
macrophage CSF or M-CSF) has been found to be an essen-
tial factor for the growth, survival, and diVerentiation of
monocyte/macrophages (Stanley et al. 1997). Furthermore,
CSF1 has important roles in DC diVerentiation and func-
tion. CSF1 upregulates human monocyte expression of the
P2X7 extracellular ATP receptor (Zhang et al. 2005),
which regulates DCs and macrophage inXammatory func-
tion, favoring the generation of cytokines that stimulate T
helper 2 responses (la Sala et al. 2003).
CSF1 acts via speciWc binding to its high-aYnity recep-
tor CSF1R (CD115 antigen), encoded by the c-fms proto-
oncogene. Upon binding, CSF1 induces CSF1R tyrosine
phosphorylation, leading to the activation of Ras-ERK and
PI3K and to the formation of DNA-binding complexes con-
taining STAT-1, STAT-3, and STAT-5 (Hamilton 1997). The
human CSF1R gene is located on chromosome 5q33–q35.
Whole-genome analyses have shown that chromosome
region 5q33–q35 contains a gene cluster of ADRB2 and
IL17RB receptors, key molecules contributing to the devel-
opment of asthma and atopy in several ethnic populations
(Holberg et al. 2001; Ober et al. 1998; Xu et al. 2001;
Yokouchi et al. 2000). Considering these biological eVects
of  CSF1R and its linkage to chromosome 5q33–q35,
genetic variants of CSF1R may be involved in asthma.
However, no report has examined its association with
asthma development. In an eVort to discover polymor-
phism(s) in the CSF1R gene that may have eVects in asthma
and related phenotypes, we identiWed 28 SNPs of the
CSF1R gene and genotyped them in 498 asthmatic patients
and 306 normal controls.
Materials and methods
Subjects
Subjects were recruited from the Genome Research Center
for Allergy and Respiratory Diseases at Soonchunhyang
University, Bucheon, Seoul, and Chunan Hospital, Korea.
All patients were diagnosed by a physician and met the
deWnition of asthma in the Global Initiative for Asthma
(GINA) guidelines (Bateman et al. 2008). All patients had a
history of dyspnea and wheezing during the previous
12 months, plus one of the following: (1) >15% increase in
FEV1 or >12% increase plus 200 mL following inhalation
of a short-acting bronchodilator, (2) <10 mg/mL PC20
methacholine, and (3) >20% increase in FEV1 following
2 weeks of treatment with systemic or inhaled steroids and
long-acting bronchodilators. The normal subjects were
recruited from the patients’ spouses and members of the
general population who had no respiratory symptoms and
had an FEV1 > 75% of the predicted value, PC20 metha-
choline >10 mg/mL, and normal Wndings on a plain chest
X-ray. Twenty-four common inhalant allergens [e.g., dust
mites (Dermatophagoides farinae and D. pteronyssinus),
aspergillus, cat fur, dog fur, cockroaches, grasses, trees,
and ragweed pollens] were used for a skin prick test. Atopy
was deWned as having a wheal reaction greater than or
equal to histamine or 3 mm in diameter. Total IgE was
measured using the Fluoroenzymeimmunoassay (Phadia
AB, Uppsala, Sweden). Written informed consent was
obtained from all subjects. Study protocols were approved
by the Institutional Review Board of Soonchunhyang
University Hospital.
Sequence analysis of human CSF1R
We sequenced CSF1R gene, including a promoter region
(1.5 kb), to discover single nucleotide polymorphisms
(SNPs) in DNA samples from 24 Koreans using the Big-
Dye Terminator (v3.1) Cycle Sequencing Kit (Applied Bio-
systems, Foster City, CA, USA) and an ABI PRISM 3700
DNA analyzer (Applied Biosystems). The primer sets used
for ampliWcation and sequencing were designed based on
sequence information from GenBank (Ref. Genome seq.;Hum Genet (2010) 128:293–302 295
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NC_000005.8). Information regarding primers is given
in Supplementary Table 1 (http://www.snp-genetics.com/
reference/additional_list.asp).
SNP selection and genotyping
Nineteen SNPs discovered in the CSF1R gene and nine
SNPs in the International HapMap database (http://hapmap.
ncbi.nlm.nih.gov/) were selected for this study (Fig. 1b).
These included three SNPs in the promoter (¡27162C>T,
¡27068C>G, and ¡27022C>T), 21 SNPs in introns
(¡26465G>A, ¡26306G>A, +5815C>T, +6610A>G, +849
8T>C, +9180C>T, +9219A>T, +11680G>T, +13198G>A,
+14665G>A, +15629G>A, +18363C>T, +20511C>T,
+21997C>T, +22693T>C, +23443G>A, +25268C>T,
+25995C>G, +28801C>G, +29446G>A, and +30473C>A),
three SNPs in exons (+5648C>T, +8313C>T, and
+15859A>G), and one SNP in the 3-UTR (+33128A>G).
The SNPs were genotyped at a multiplex level using Illu-
mina’s Golden Gate genotyping system (Oliphant et al.
2002), and data quality was assessed using duplicate DNA
(n = 10). The genotype quality score for keeping data was
set to 0.25. SNPs that could not satisfy the following crite-
ria were excluded: (1) a minimum call rate of 90%, (2) no
duplicate error, and (3) Hardy–Weinberg equilibrium
greater than p > 0.001. Twenty-eight SNPs were success-
fully genotyped. Information about the primers is provided
in Supplementary Table 1.
Measurement of CSF1R protein expression 
on CD14-positive monocytes and neutrophils 
of asthmatic patients
Neutrophils and mononuclear cells (PBMC) were puriWed
from the heparinized peripheral blood of asthmatic patients
using a Percoll gradient (1.115, 1.100, 1.090, and 1.070).
Mouse anti-human M-CSF R mAb (R&D Systems, Minne-
apolis, USA) was incubated with 5 £ 105 PBMC or neutro-
phils, followed by treatment with 50 g of PE-conjugated
goat anti-mouse IgG (BD Biosciences, San Jose, CA, USA)
for  CSF1R staining. Additionally, PBMC was incubated
with FITC-conjugated mouse anti-human CD14 (BD Bio-
sciences). Stained cells were analyzed using a Xow cytome-
ter (FACScan, Becton-Dickinson, Mountain View, CA,
USA). For isotype-matched controls, PE-conjugated mouse
IgG1 (R&D Systems) and FITC-conjugated mouse IgG2a
kappa (BD Biosciences) were used, with the same concen-
tration of each antibody tested.
RNA extraction and real-time PCR of CSF1R m-RNA
Total RNA was isolated from neutrophils using a modiWed
guanidium thiocyanate–phenol–chloroform extraction method
(Schreiber et al. 1989). We quantiWed RNA and reverse
transcribed cDNA from 3 g of total RNA. DNase I
(10,000 U/mL; Stratagene, La Jolla, CA, USA)-treated
RNA was reverse-transcribed by incubating with 0.5 mM
dNTP, 2.5 mM MgCl2, 5 mM DTT, 1 L of random hexa-
mer (50 g/L), and SuperScript II RT (200 unit/L, Life
Technologies, Grand Island, NY, USA) at 42°C for 50 min,
and heat-inactivated at 70°C for 15 min.
SpeciWc primer pairs for RT-PCR were as follows:
-actin forward: 5-GGACTTCGAGCAAGAGATGG-3;
-actin reverse: 5-AGCACTGTGTTGGCGTACAG-3
and CSF1R forward: 5-CACCTTCACCCTCTCTCTGC-3;
CSF1R reverse: 5-AGCATCTTCACAGCCACCTT-3.
AmpliWcation was performed for 30 cycles (one cycle: 30 s
at 94°C, 30 s at 55°C, and 40 s at 72°C) with initial dena-
turation at 94°C for 5 min and a Wnal extension at 72°C for
10 min. The size and amount of the PCR products
generated were determined by agarose gel electrophoresis
in the presence of ethidium bromide and analyzed with the
Kodak EDAS 1D analysis package. The cDNA fragment of
the CSF1R gene contained from exon10 to exon12.
cDNA was aliquoted into tubes containing speciWc
primer pairs for human PGK1 (phosphoglycerate
kinase1), human -actin, and CSF1R genes for ampliW-
cation (191, 233, and 263 bp fragments, respectively)
using RT-PCR. Nucleotide sequences of the primers
were as follows: PGK1 forward: 5-CCTGGGCGG
AGCTAAAGTTG-3; PGK1 reverse: 5-T CTCAGCTTTGG
ACATTAGGTCT-3; -actin forward:   5-GGACTTCGA
GCAAGAGATGG-3; -actin reverse:   5-AGCACTGTGT
TGGCGTACAG-3; CSF1R forward:   5-CAGAGCCT
GCTGACTGTTGA-3; CSF1R reverse: 5-TTGCCCTCATA
GCTCTCGAT-3. The primers of PGK1 and -actin were
prepared using the Primerbank web server (http://pga.
mgh.harvard.edu/primerbank/). RT-PCR was performed
with the StepOne™ Real-Time PCR System (Applied Bio-
systems, CA, USA). The reactions were prepared with
20 L PCR mixture consisting of 10 L master mix (iQ
SYBR Green Supermix; Bio-Rad, Hercules, CA, USA),
1 g/L cDNA template, and 1 L each of the CSF1R
primer pair. Reactions were denatured at 95°C for 10 min
and ampliWed for 40 cycles at 95°C for 15 s, 57°C for 32 s,
and 72°C for 30 s. A melting curve for all products was
obtained immediately after ampliWcation by increasing
temperature in 0.3°C increments from 60°C for 85 cycles of
15 s each. The threshold cycle (Ct) of CSF1R or endoge-
nous reference gene was deWned as the fractional cycle
number at which the Xuorescence of PCR products passed
the Wxed threshold. Using the 2¡Ct method, the data are
presented as the fold change in gene expression, normalized
to an endogenous reference gene (PGK1 and -actin) and
relative to a control (+22693 TT and +22693 CC genotype
of CSF1R). For the control sample, Ct equals zero and296 Hum Genet (2010) 128:293–302
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20 = 1, so that the fold change in gene expression relative to
the control = 1, by deWnition (Livak and Schmittgen 2001).
For the other samples, evaluation of 2¡Ct indicates the
fold change in gene expression relative to the control. Fold
diVerences in CSF1R mRNA expression in each patient
were also calculated by comparing 2¡Ct.
Statistical analyses
Linkage disequilibria (LD) between loci were measured as
Lewontin’s D (|D|) and r2. Haplotypes of each individual
were inferred using the algorithm (PHASE, version 2.0),
developed by Stephens et al. (2001). The associations of
Fig. 1 Gene map, p value, haplotype list, and linkage disequilibrium
of SNPs in the CSF1R gene. a Log p values for the association analysis
of SNPs with asthma risk. b Gene map and locations of the SNPs in the
CSF1R gene at chromosome 5q33–q35 (60 kb). The Wrst base of the
translation start site is denoted as nucleotide +1. The black and white
blocks represent the untranslated regions and coding regions of
CSF1R, respectively. *polymorphisms selected for large-scale geno-
typing, considering allele frequencies, locations, and LD after discov-
ery. **SNPs selected in the HapMap database. p values of each SNP
were demonstrated in three diVerent models (co-dominant, dominant,
and recessive). c Haplotypes of CSF1R.  d Linkage disequilibrium
coeYcient (|D| and r2) among CSF1R SNPs
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CSF1R genotypes and haplotypes with the risk of asthma
were analyzed by logistic analysis, controlling for age (con-
tinuous value), gender (male = 0, female = 1), smoking sta-
tus (non-smoker = 0, ex-smoker = 1, smoker = 2) and atopy
status (non-atopy = 0, atopy = 1) as co-variables. Statistical
analyses were performed using the SAS (v9.1; SAS Insti-
tute, Cary, NC, USA) and SPSS software (v11; SPSS, Inc.,
Chicago, IL, USA). p values of <0.05 were deemed to indi-
cate statistical signiWcance. The eVective number of inde-
pendent marker loci in CSF1R was calculated to correct for
multiple testing using SNPSpD (http://genepi.qimr.edu.au/
general/daleN/SNPSpD/) based on the spectral decomposi-
tion (SpD) of matrices of pair-wise LD between SNPs
(Nyholt  2004). The number of independent marker loci
in CSF1R was calculated as 4.5008 and 20.0301 in CSF1R-
ht-block1 and CSF1R-ht-block2. The Wnal number of
independent marker loci in CSF1R was 24.531. In vitro
analysis, diVerences between independent groups and samples
were evaluated using a non-parametric Kruskal–Wallis
H test for continuous data. When signiWcant diVerences
were found, a Mann–Whitney U test was performed to
detect diVerences between pairs of samples. Statistical
signiWcance was deWned as p < 0.05.
Results
Characteristics of the study subjects
The clinical characteristics of the study subjects are sum-
marized in Table 1. SigniWcant diVerences were found in
mean age and prevalence of smoking between the normal
controls and asthmatic patients (p =0 . 0 0 1 ) .  F V C ,  F E V 1,
and PC20 values were signiWcantly lower in the asthmatic
subjects than in the normal controls (p < 0.001). IgE level,
atopy prevalence, and eosinophil number were signiWcantly
higher in the asthmatic patients (p < 0.001).
Association of SNPs in CSF1R with asthma risk
Pair-wise comparisons of the SNPs revealed two sets of
absolute LDs (|D| = 1 and r2 =1 :   ¡27068C>G, ¡27022C>
T; +13198G>A, +14665G>A); several complete LDs
(|D| = 1 and r2  1) were also found (Fig. 1d). Haplotypes
of CSF1R were constructed using the PHASE software, and
eight major haplotypes with over 5% of MAF were used for
Fig. 1 continued D LDs among CSF1R polymorphisms
Table 1 Clinical proWle and laboratory Wndings of the study subjects
Values are mean § SE
* p = 0.001 and ** p < 0.001 are obtained using t test or 2 test
between asthmatics and normal controls
Normal controls Asthmatics
Number 303 498
Age (year, range) 48 (8–83) 43 (11–87)*
Onset of age (year, range) 41 (1–75)
Percentage of males 44.3 45.1
Current/ex-smoker (%) 17.5/11.8 17/20*
FVC (% predicted) 93.7 § 12.4 82.9 § 18.1**
FEV1 (% predicted) 103.09 § 14.77 79.33 § 22.18**
PC20 methacholine (mg/ml) 24.29 § 2.47 4.02 § 6.17**
Total IgE (IU/ml) 115.9 § 10.8 420.0 § 55.1**
Peripheral blood 
eosinophil (%)
2.5 § 0.1 5.6 § 0.25**
Atopy (%) 33.1 62.5**298 Hum Genet (2010) 128:293–302
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further statistical analyses (Fig. 1c). The genotype distribu-
tions of the 28 SNPs were in Hardy–Weinberg equilibrium
for all subjects (p > 0.05, Supplementary Table 2). The fre-
quency of each of the 28 polymorphisms and eight haplo-
types was compared between the asthmatic participants and
normal controls using logistic regression. The allele fre-
quencies in the asthmatic and normal control subjects are
shown in Supplemental Table 3, and the p values of each
SNP are shown in Fig. 1a. Among the 28 polymorphisms
tested, two intronic polymorphisms (+20511C>T and
+22693T>C) were associated with asthma risk (Fig. 1a;
Table 2;  p = 0.001 in co-dominant and dominant models
and p = 0.0006 in a recessive model). After correcting for
multiple comparisons, the diVerence remained signiWcant in
the two CSF1R SNPs (p = 0.02 and 0.01, respectively).
Frequencies of the T alleles at CSF1R +20511C>T in the
asthmatic group were higher than in the normal control
group (49.5 vs. 36.7%, OR = 1.55, p = 0.001). In the
analysis of the recessive model, the frequency of the
C allele at CSF1R +22693T>C in the asthmatic group was
higher than in the normal control group (25.8 vs. 16.4%,
OR = 1.99, p = 0.0006). The data suggest that the T alleles
at  CSF1R + 20511C>T and the C allele at CSF1R
+22693T>C have a genetic susceptibility eVect on the
development of asthma.
Flow cytometric analysis for CSF1R protein expression 
on peripheral blood CD14-positive monocytes 
and neutrophils from asthmatic subjects
The CSF1R expression was measured on peripheral blood
neutrophils and CD14-positive monocytes obtained from
asthmatic patients by Xow cytometry (Fig. 2). The CD14+
monocytes from asthmatic patients with the C alleles at
+22693T>C showed signiWcantly higher CSF1R expres-
sion than those with the TT alleles at +22693T>C
(46.33 § 4.62 vs. 83.52 § 12.64, p = 0.045; Fig. 2e). The
expression showed a similar trend in neutrophils. The level
of CSF1R expression was signiWcantly increased on neu-
trophils having the +22693 CC alleles versus those having
+22693 T alleles (2.42 § 0.3 vs. 5.62 § 1.75, p = 0.044;
Fig. 2f). In contrast, CSF1R expression was not diVerent
according to the genotypes of CSF1R +20511C>T (data
not shown).
Comparison of CSF1R mRNA levels from its SNP 
subtypes
To investigate the genetic eVect of the +22693 T>C poly-
morphism on mRNA expression of the CSF1R gene in neu-
trophils,  CSF1R mRNA levels were measured. Because
CSF1R +22693 T>C is located in intron 11, we ampliWed
mRNA containing the CSF1R gene using primers to detect
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alternative splicing, as described in “Materials and meth-
ods” and Fig. 3a. To identify the RT-PCR products,
sequences were examined using the BLAST search pro-
gram after direct sequencing. The ampliWed RT-PCR frag-
ment from exon 8 to exon 13 was 758 bp in length (Fig. 3b)
and that of the RT-PCR product from exon 10 to exon 12
was 263 bp. Both of them shared 100% sequence identity
with the human CSF1R gene. In the RT-PCR products, no
alternative splicing was found in the common or rare homo-
zygotes of +22693 T>C (Fig. 3b). Quantitation of mRNA
expression in neutrophils from 12 asthmatics was per-
formed by determining the concentration of the CSF1R RT-
PCR products, corrected by that of -actin and PGK1
(Fig. 3c). The expression level of total CSF1R mRNA in
neutrophils was higher in patients having +22693 T alleles
versus those having +22693 C alleles (Fig. 3d).
Discussion
In this study, we identiWed 28 genetic variants in the exons,
introns, and Xanking region of the CSF1R gene. Among
them, we discovered that two polymorphisms in introns
were associated with a risk of asthma development by
logistic analysis. The rare allele frequencies of CSF1R
+20511C>T and CSF1R + 22693T>C were signiWcantly
higher in asthmatic patients versus normal controls, and
this remained signiWcant after correcting for multiple
Fig. 2 CSF1R protein expres-
sion on CD14+ monocytes and 
neutrophils in the peripheral 
blood of asthmatic subjects. 
a Gating for CD14+ among 
monocytes using an FITC-con-
jugated CD14 Ab. b Gating for 
neutrophils using side scatter 
and forward scatter. c, e Levels 
of CSF1R expression were com-
pared between monocytes from 
asthmatic patients with the T or 
C alleles on CSF1R +22693T>C. 
d, f Levels of CSF1R expression 
were compared between neutro-
phils from asthmatic patients 
having the C allele at CSF1R 
+22693T>C and having the 
T allele at CSF1R +22693T>C
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comparisons. This indicates that the rare alleles, CSF1R
+20511C>T and CSF1R +22693T>C, in the intron may have
some genetic susceptibility eVect on the risk of asthma.
Genetic variants exert their eVects via alteration of the
gene product, the protein. The eVects of CSF1 are mediated
by the CSF1 receptor tyrosine kinase (CSF1R) through
autophosphorylation of CSF1R and the subsequent phos-
phorylation of downstream molecules. Triggering this
phosphorylation cascade increases gene transcription and
protein translation and induces cytoskeletal remodeling by
several signaling pathways, leading to the survival, prolif-
eration, and diVerentiation of target cells (Pixley and Stan-
ley 2004). Functional derangement of phosphorylation of
CSF1R has been documented in pulmonary alveolar pro-
teinosis (PAP). PAP is an autoimmune disorder in which
autoantibodies interfere with signaling through the granulo-
cyte–macrophage colony-stimulating factor receptor, lead-
ing to macrophage and neutrophil dysfunction (Juvet et al.
2008). Additionally, CSF1 is able to prime some innate
immune responses by modulation of Toll-like receptors.
Stimulation of monocytes and macrophages with CSF1
downregulates the expression of TLR1, TLR5, TLR2, TLR6,
and TLR9 (O’Mahony et al. 2008; Sweet et al. 2002) and
increases expression of CD14 (Ji et al. 2004). Thus, CSF1
enhances cytokine production in response to LPS, but
suppresses the CpG DNA response (Sweet et al. 2002).
These data suggest that CSF1R expression may be associ-
ated with various inXammatory responses, including the
innate immune response, in asthma pathogenesis. However,
no association between genetic variants in the CSF1R gene
or protein has been documented in asthma.
The intronic SNPs of CSF1R gene in the present study
may lead to diVerential production in the quantity of
CSF1R protein or to structural variants. Thus, functional
validation is necessary to conWrm the genetic eVect. To val-
idate the genetic eVect of CSF1R +20511C>T and CSF1R
+22693T>C, the protein level on neutrophils and mono-
cytes was analyzed by Xow cytometry because these cells
are known to express the receptor on their surface (Buckle
et al. 1990). To separate monocytes clearly by Xow cytome-
try, CD14+ cells were gated to eliminate other cells. Asth-
matic patients having the rare alleles had signiWcantly
increased  CSF1R expression on neutrophils and CD14+
monocytes compared with those with the common
+22693T>C T alleles. These data indicate that the rare
allele genotype increases protein expression of CSF1R
gene, leading to asthma development via diVerential regula-
tion of neutrophils, monocytes, and other immune cells,
including dendritic cells, although we did not measure
CSF1R protein expression on dendritic cells. Interestingly,
Fig. 3 Comparison of CSF1R mRNA levels from its SNP subtypes.
a Diagram of PCR primers. The RT-PCR product size from exon 8 to
exon 13 is 758 bp. The RT-PCR product size from exon 10 to exon 12
is 263 bp. b Neutrophils containing T allele or C allele were harvested,
and CSF1R mRNA was measured using RT-PCR. c Melt curve using
RT-PCR is shown. d CSF1R mRNA was measured using RT-PCR.
Data are expressed as the ratio of CSF1R mRNA over -actin and
PGK1 mRNA. The experiments were performed in duplicate
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CSF1R expression was independent from the CSF1R
+20511C>T genotype.
It is well known that intronic SNPs can aVect transcript
processing through alternative splicing or producing RNA
secondary structure (Chen and Stephan 2003). Because the
CSF1R + 22693T>C is located in the intron, we next
checked the presence of alternatively spliced forms of
CSF1R by RT-PCR.
No alternative splicing was found in the subjects having
rare or common homozygotes. Thus, one of the explana-
tions for the diVerential protein expression of the CSF1R
gene may be diVerent mRNA production, due to a change
in RNA secondary structure according to genotype (Zuker
2003). The secondary structure containing the C allele
of +22693T>C has a G of ¡127.25 kcal/mol, and the
T allele has a G of ¡131.45 kcal/mol (Supplemental
Fig. 1). These data suggest that this SNP may aVect the sec-
ondary structure of the CSF1R gene. To validate the func-
tional eVect of the +22693 T>C on RNA processing, we
measured mRNA levels using RT-PCR. We found that
mRNA expression in neutrophils having the C alleles at
+22693 C was signiWcantly higher than in those having the
T alleles at +22693. This indicates that the diVerential RNA
production may be derived from a genetic eVect of the SNP.
In summary, we genotyped human CSF1R gene poly-
morphisms and found that the rare allele CSF1R
+22693T>C was associated with the risk of asthma via
increasing CSF1R mRNA and protein expression on neu-
trophils and monocytes. This information on the genetic
polymorphism of the CSF1R gene may be useful for
improving asthma treatment and developing new strategies
for controlling bronchial asthma.
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